心筋保護法標準テキストブック

出版社： 文光堂
著者：
発行日： 2016-02-02
分野： 臨床医学：外科  >  心臓/血管外科
ISBN： 9784830619281
電子書籍版： 2016-02-02 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

7,150 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

7,150 円(税込)

購入する

商品紹介

心臓手術に携わる医師・臨床工学技士に正しい心筋保護法を理解してもらうため日本心臓血管外科学会で編集・執筆したテキスト．

目次

  • 心筋保護法標準テキストブック

    ―目次―

    1章　心臓の解剖・生理・代謝
    　1）心臓の解剖と冠循環および心筋細胞
    　2）心筋細胞の生理：興奮収縮連関
    　3）心筋細胞の生理：細胞機能維持
    　4）心筋細胞の代謝：細胞のエネルギー獲得
    2章　未熟心筋とチアノーゼ
    3章　加齢心筋，肥大心筋，不全心筋
    4章　心筋の虚血再灌流傷害
    5章　開心術における心筋保護の原則
    6章　心筋保護・心保存の歴史的変遷
    7章　現行心筋保護法
    　1）晶質液心筋保護法
    　2）血液心筋保護法
    　3）心筋保護液の投与方式
    　4）統合型血液心筋保護法
    　5）常温心臓手術
    　6）現行心筋保護法の問題点
    8章　現行心保存法
    9章　心保存の手技
    10章　新しい心筋保護・心保存の未来像
    　　　　―心筋再生効果を有する薬剤を用いた
    　　　　　新しい心筋虚血再灌流傷害治療法―
    11章　術中心筋保護の手技
    12章　術中心筋保護の管理
    13章　手術室やICUにおける心筋保護効果の評価
    14章　基礎（併存）疾患を有する症例の心筋保護
    15章　各疾患における開心術中心筋保護
    　1）はじめに：心筋保護法の現況と成績
    　2）冠動脈疾患
    　3）弁膜疾患
    　4）心筋症
    　5）大動脈疾患
    　6）小児心臓疾患
    16章　開心術中心筋保護や心保存に関するFAQ集
    　　　（クリニカルクエスチョンとアンサー）
    17章　開心術中心筋保護の現状
    　　　（全国アンケート調査報告）
    18章　心筋保護関連材料の現状および業務施行上の安全管理
    19章　さらに勉強したい人のための参考図書および参考文献集

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 心臓の解剖・生理・代謝

P.5 掲載の参考文献
1) Sawabe M, Saito M, Naka M et al : Standard organ weights among elderly Japanese who died in hospital, including 50 centenarians. Pathol Int 56 : 315-323, 2006
PubMed
2) Vogel WM, Briggs LL, Apstein CS : Separation of inherent diastolic myocardial fiber tension and coronary vascular erectile contributions to all stiffness of rabbit hearts damaged by ischemia, hypoxia, calcium paradox and reperfusion. J Mol Cell Cardiol 17 : 57-70, 1985
PubMed
3) Rakusan K, Rochemont WM, Braasch W et al : Capacity of the terminal vascular bed during normal growth, in cardiomegaly, and in cardiac atrophy. Circ Res 21 : 209-215, 1967
 
4) Yamamoto H, Avkiran M : Changes in coronary vasodilatory reserve induced by pressure overload during post-natal development : effects on post-ischemic perfusion. Eur J Cardiothorac Surg 7 : 26-33, 1993
PubMed
P.10 掲載の参考文献
1) Solaro RJ, el-Saleh SC, Kentish JC : Ca2+, pH and the regulation of cardiac myofilament force and ATPase activity. Mol Cell Biochem 7 : 163-167, 1989
PubMed
2) Gao WD, Atar D, Backx PH, et al : Relationship between intracellular calcium and contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+responsiveness and altered diastolic in intact ventricular muscle. Cir Res 76 : 1036-1048, 1995
 
3) Bolli R, Marban E : Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 : 609-634, 1999
PubMed
4) Wei JY, Spurgeon HA, Lakatta EG : Excitation-contaction in rat myocardium : alteration with adult aging. Am J Physiol 246 : H784-H791, 1984
 
5) Lakatta EG : Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73 : 413-467, 1993
PubMed
6) Korzick DH : Regulation of cardiac excitation-contraction coupling : A cellular update. Adv Physiol Educ 27 : 192-200, 2003
PubMed
7) Williams GSB, Boyman L, Chikando AC et al : Mitochondrial calcium uptake. PNAS 110 : 10479-10486, 2013
PubMed
8) Opie LH : Myocardial contraction and relaxation. in : Opie LH ed : The Heart. Physiology, from Cell to Circulation, 3rd ed. Lippincott-Raven Publishers, Philadelphia, 1998, pp209-231
 
9) Lakatta EG, Maltsev VA, Vinograova TM : A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 106 : 659-673, 2010
 
P.14 掲載の参考文献
1) Geers C, Gros G : Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 80 : 681-715, 2000
PubMed
2) 後藤昌義 : 興奮性細胞膜と心筋細胞の特性. in : 心臓の生理. 南江堂, 1984, pp23-47
 
3) Opie LH : Channels, Pumps, and Echangers. in : Opie LH ed : The Heart, Physiology, from Cell to Circulation, 3rd ed. Lippincott-Raven Publishers, Philadelphia, 1998, pp71-114
 
4) 沼田朋, 香西大輔, 高橋重成ほか : TRP チャネルの構造と多様な機能. 生化学 81 : 962-983, 2009
 
P.17 掲載の参考文献
1) 中村運 : エネルギー代謝とは何だろう. in : 新・細胞の起源と進化 生命のしくみを探る. 培風館, 2006, pp152-197
 
2) 石川統, 山岸明彦, 河野重行ほか : シリーズ進化学 化学進化・細胞進化. 岩波書店, 2004, pp55-103
 
3) Opie LH : Fuels : Aerobic and anaerobic metabolism. in : Opie LH ed : The Heart, Physiology, from Cell to Circulation, 3rd ed. Lippincott-Raven Publishers, Philadelphia, 1998, pp295-342
 

2章 未熟心筋とチアノーゼ

P.21 掲載の参考文献
1) Nakanishi T, Seguchi M, Takao A : Development of the myocardial contractile system. Experientia 44 : 936-944, 1988
PubMed
2) Cohen NM, Lederer WJ : Changes in the calcium current of rat heart ventricular myocytes during development. J Physiol (Lond) 406 : 115-146, 1988
PubMed
3) Vornanen M : Force-frequency relationship, contraction duration, and recirculating fraction of calcium in postnatally developing rat heart ventricles : correlation with heart rate. Acta Physiol Scand 145 : 311-321, 1992
PubMed
4) 石渡隆寛, 滝沢真理, 川村陽一ほか : マウスwhole heartを用いた心発生過程における筋小胞体機能解析. 日小循会誌 28 : 195-202, 2012
 
5) Okubo C, Sano HI, Naito Y et al : Contribution of quantitative change in individual ionic current systems to the embryonic development of ventricular myocytes : a simulation study. J Physiol Sci 63 : 355-367, 2013
 
6) 白石公 : 心筋細胞収縮におけるcalcium handling : 成熟心筋と未熟心筋. 日小循会誌 28 : 203-205, 2012
 
7) Chen F, Mottino G, Klitzer T et al : Distribution of the Na+/Ca2+ exchange protein in developing rabbit myocytes. Am J Physiol 268 : C1126-C1132, 1995
PubMed
8) Rolph TP, Jones CT, Parry D : Ultrastructural and enzymatic development of fetal guinea pig heart. Am J Physiol 243 : H87-H93, 1982
PubMed
9) Rakusan K, Rochemont WM, Braasch W et al : Capacity of the terminal vascular bed during normal growth, in cardiomegaly, and in cardiac atrophy. Circ Res 21 : 209-215, 1967
 
10) Yamamoto H, Avkiran M : Changes in coronary vasodilatory reserve induced by pressure overload during post-natal development : effects on post-ischemic perfusion. Eur J Cardiothorac Surg 7 : 26-33, 1993
PubMed
11) Tomanek RJ, Ratajska A, Kitten GT et al : Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 215 : 54-61, 1999
PubMed
12) Sasaki H, Fukuda S, Otani H et al : Hypoxic preconditioning triggers myocardial angiogenesis : a novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol 34 : 335-348, 2002
PubMed
13) Olszewska-Pazdrak B, Hein TW, Olszewska P et al : Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol 296 : C1162-C1170, 2009
 

3章 加齢心筋, 肥大心筋, 不全心筋

P.24 掲載の参考文献
1) Walker KE, Houser SR : Intracellular calcium buffers affect age-related calcium current decay. Circulation 82 (Suppl III) : III-747, 1990
 
2) Dubell WH, Boyett MR, Spurgeon HA et al : The cytosolic calcium transient modulates the action potential of rat ventricular myocyte. J Physiol (Lond) 436 : 347-369, 1991
PubMed
3) Ruch S, Im WB, Kennedy RH et al : Aging : stimulation rate of cardiac intracellular Na+ activity and developed tension. Mech Ageing Dev 60 : 303-313, 1991
PubMed
4) Lakatta EG : Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73 : 413-467, 1993
PubMed
5) Scoote M, Williams AJ : The cardiac ryanodine receptor (calcium release channel) : Emerging role in heart failure and arrhythmia pathogenesis. Cardiovasc Res 56 : 359-372, 2002
PubMed
6) Dobromir D, Wehrens XHT : Role of RyR2 phosphorylation in heart failure and arrhythmias. Circ Res 114 : 1311-1319, 2014
 
7) Inuzuka Y, Okuda J, Kawashima T et al : Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 120 : 1695-1703, 2009
PubMed
8) 康東天 : 疾患の制御・修飾因子としてのミトコンドリア. 生化学 85 : 160-166, 2014
 
9) Ikeuchi M, Matsusaka H, Kang D et al : Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation 112 : 683-690, 2005
PubMed
10) Fujino T, Ide T, Yoshida M et al : Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes. Mitochondrion 12 : 449-458, 2012
PubMed
11) Hayashi Y, Yoshida M, Yamato M et al : Reverse of age-dependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor A in mice. J Neurosci 28 : 8624-8634, 2008
PubMed
12) Huhn R, Weber NC, Preckel B et al : Age-related loss of cardiac preconditioning : Impact of protein kinase A. Exp Gerontol 47 : 116-121, 2012
PubMed
13) Heinen A, Strothoff M, Schmidt A et al : Pharmacological options to protect the aged heart from ischemia and reperfusion injury by targeting the PKA-BKCa signaling pathway. Exp Gerontol 56 : 99-105, 2014
PubMed
14) Lee TM, Su SF, Chou TF et al : Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105 : 334-340, 2002
PubMed

4章 心筋の虚血再灌流傷害

P.37 掲載の参考文献
1) Ibanez B, Heusch G, Ovize M et al : Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol 65 : 1454-1471, 2015
PubMed
2) Hausenloy DJ, Yellon DM : Myocardial ischemia-reperfusion injury : a neglected therapeutic target. J Clin Invest 123 : 92-100, 2013
PubMed
3) Yellon DM, Hausenloy DJ : Myocardial reperfusion injury. N Engl J Med 357 : 1121-1135, 2007
PubMed
4) Fukushima S, Coppen SR, Varela-Carver A et al : Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration. Cardiovasc Res 69 : 459-465, 2006
PubMed
5) Bers DM : Cardiac excitation-contraction coupling. Nature 415 : 198-205, 2002
PubMed
6) Fukushima S, Campbell NG, Coppen SR et al : Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. J Heart Lung Transplant 30 : 227-233, 2011
PubMed
7) Fukushima S, Coppen SR, Varela-Carver A et al : A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. Circulation 114 (Suppl 1) : 251-256, 2006
 
8) Frangogiannis NG : The inflammatory response in myocardial injury, repair, and remodeling. Nat Rev Cardiol 11 : 255-265, 2014
PubMed
9) Betgem RP, de Waard GA, Nijveldt R et al : Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 12 : 156-167, 2015
PubMed
10) Shintani Y, Drexler HC, Kioka H et al : Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep 15 : 438-445, 2014
PubMed
11) Sawa Y, Taniguchi K, Kadoba K et al : Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation 93 : 1640-1646, 1996
PubMed
12) Chambers DJ, Fallouh HB : Cardioplegia and cardiac surgery : Pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther 127 : 41-52, 2010
PubMed

5章 開心術における心筋保護の原則

P.43 掲載の参考文献
1) Chitwood WR, Sink JD, Hill R et al : The effects of hypothermia on myocardial oxygen consumption and transmural coronary blood flow in the potassium-arrested heart. Ann Surg 190 : 106-116, 1979
PubMed
2) Bretschneider HJ, Hubner G, Knoll D et al : Myocardial resistance and tolerance to ischemia. J Cardiovasc Surg 16 : 241-260, 1975
PubMed
3) Barner HB : Historical aspects and current review of myocardial protection. in : Salerno TA ed : Warm Heart Surgery. Arnold, a member of the Hodder Heardline Group, London 1995, pp1-15
 
4) Hearse DJ, Braimbridge MV, Jynge P : Cardioplegic solutions in clinical use. in : Hearse DJ, Braimbridge MV, Jynge P eds : Protection of the Ischemic Myocardium : Cardioplegia. Raven Press Books, Ltd, New York, 1981, pp341-352
 
5) Hearse DJ, Stewart DA, Chain EB : Recovery from cardiac bypass and elective cardiac arrest. The metabolic consequences of various cardioplegic procedures in the isolated rat heart. Circ Res 35 : 448-457, 1974
PubMed
6) Hayashida N, Ikonomidis JS, Weisei RD et al : The optimal cardioplegic temperature. An Thorac Surg 58 : 961-971, 1994
 
7) Anyanwu E, Konermann C, Klinke F et al : The influence of non-coronary collateral blood supply on the electively arrested heart during ischemia and reperfusion. Res Exp Med (Berl) 182 : 111-126, 1983
PubMed
8) Caldarone CA, Krukenkamp IB, Misare BD et al : Perfusion deficits with retrograde warm blood cardioplegia. Ann Thorac Surg 57 : 403-406, 1994
PubMed
9) Fleckenstein A, Janke J, Doring HJ et al : Ca overload as the determinant factor in the production of catecholamine-induce myocardial lesions. in : Bajusz E, Rona G, Brink J et al eds : Recent Advances in Studies on Cardiac Structure and Metabolism, Vol 2 : Cardiomyopathies. MTP Press, Lancaster, 1973, pp455-466
 
10) Denis SC, Gevers W, Opie LH : Protons in ischemia : where do they come from ; where do they go to? J Mol Cell Cardiol 23 : 1077-1086, 1991
 
11) Satoh H, Hayashi H, Kato H et al : Na+/H+ and Na+/Ca2+ exchange in regulation of [Na+]i and [Ca2+]i during metabolic inhibition. Am J Physiol 268 : H1239-H1248, 1995
 
12) Pike MM, Kitakaze M, Marban E : 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am J Physiol 259 : H1767-H1773, 1990
PubMed
13) Doering AE, Lederer WJ : The mechanism by which cytoplasmic protons inhibit the sodium-calcium exchanger in guinea-pig heart cells. J Physiol 466 : 481-499, 1993
 
14) Boyce SW, Bartels C, Bolli R et al : Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients : results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg 126 : 420-427, 2003
PubMed
15) Mentzer RM Jr, Bartels C, Bolli R et al : Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting : results of the EXPEDITION study. Ann Thorac Surg 85 : 1261-1270, 2008
PubMed
16) Abah U, Roberts PG, Ishaq M et al : Is cold or warm blood cardioplegia superior for myocardial protection? Intract Cardiovasc Thorac Surg 14 : 848-855, 2012
 
17) Liakopoulos OJ, Kuhn EW, Choi YH et al : Myocardial protection in cardiac surgery patients requiring prolonged aortic cross-clamp times : a single-center evaluation of clinical outcomes comparing two blood cardioplegic strategies. J Cardiovasc Surg 51 : 895-905, 2010
PubMed
18) Ascione R, Caputo M, Gomes WJ et al : Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. Eur J Cardiothorac Surg 21 : 440-446, 2002
PubMed

6章 心筋保護・心保存の歴史的変遷

P.57 掲載の参考文献
1) Lewis FJ, Taufic M : Closure of atrial septal defects with the aid of hypothermia : experimental accomplishments and report of one successful case. Surgery 33 : 52-59, 1953
PubMed
2) Gibbon JH : Application of mechanical heart and lung apparatus to cardiac surgery. Minn Med 37 : 171-185, 1954
PubMed
3) Lillehei CW, Cohen M, Warden HE et al : The direct-vision intracardiac correction of congenital anomalies by controlled cross-circulation. Surgery 38 : 11-29, 1955
PubMed
4) Melrose DG, Dreyer B, Bentall HH et al : Elective cardiac arrest. Lancet 269 : 21-22, 1955
PubMed
5) McFarland JA, Thomas LB, Gilbert JW et al : Myocardial necrosis following elective cardiac arrest induced with potassium citrate. J Thorac Cardiovasc Surg 40 : 200-208, 1960
 
6) Shumway NE, Lowew RR : Topical cardiac hypothermia for extended periods of anoxic arrest. Surg Forum 10 : 563-566, 1960
 
7) Messmer BJ, Hallman GL, Liotta D et al : Aortic valve replacement : new technique, hydrodynamics and clinical results. Surgery 68 : 1026-1037, 1970
PubMed
8) Cooley DA, Ruel GJ, Wukasch DC : Ischemic contracture of the heart : "stone heart". Am J Cardiol 29 : 575-577, 1972
 
9) Bretschneider HJ : Uberlebenszeit und Wiederbelebungszeit des Herzens bei Normo-und Hypothermie. Verh Dtsch Ges Kreislaufforsch 30 : 11-34, 1964
PubMed
10) Kirsch U : Untersuchungen zum Eintritt der Totenstarre an ischaemischen Meerschweinchenherzen in Normothermie. Der Einfluss von Procain, Kalium und Magnesium. Arzneim Forsch 20 : 1071-1074, 1970
 
11) Braimbridge MV, Chayen J, Bitensky L et al : Cold cardioplegia or continuous coronary perfusion? J Thorac Cardiovasc Surg 74 : 900-906, 1977
PubMed
12) Jynge P, Hearse DJ, Feuvray D et al : The St Thomas' Hospital cardioplegic solution : a characterization in two species. Scand J Thorac Cardiovasc Surg 30 : 1-28, 1981
 
13) Bigelow WG, Lindsay WK, Greenwood WF : Hypothermia : its possible role in cardiac surgery. Ann Surg 132 : 849-856, 1950
PubMed
14) Rosenfeldt FL, Watson DA : Development of an in vitro midel of myocardial cooling : a study of the effect of cardiac size on cooling rate. Ann Thorac Surg 27 : 7-12, 1979
 
15) Engelman RM, Auvil J, O'Donoghue MJ et al : The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest. J Thorac Cardiovasc Surg 75 : 555-563, 1978
PubMed
16) Kirsch U, Rodewald G, Kalmar P : Induced ischemic arrest in clinical experience with cardioplegia in open heart surgery. J Thorac Cardiovasc Surg 63 : 121-130, 1972
PubMed
17) Roe BB, Hutchinson JC, Fishman NM et al : Myocardial protection with cold ischemic potassium-induced cardioplegia. J Thorac Cardiovasc Surg 73 : 366-370, 1977
 
18) Lolley DM, Ray JF, Myers WO et al : Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement : Prospective randomized study. Ann Thrac Surg 26 : 515-523, 1978
 
19) Conti VR, Bertranou EG, Blackstone EH et al : Cold cardioplegia versus hypothermia for myocardial protection : Randomized clinical study. J Thorac Cardiovasc Surg 76 : 577-586, 1978
PubMed
20) Craver JM, Sams AB, Hatcher CR et al : Potassium induced cardioplegia : Additive protection against ischemic myocardial injury during coronary revascularization. J Thorac Cardiovasc Surg 76 : 24-27, 1978
PubMed
21) Hearse DJ, Stewart DA, Braimbridge MV : Myocardial protection during ischemic cardiac arrest : Possible deleterious effects of glucose and mannitol in coronary infusates. J Thorac Cardiovasc Surg 76 : 16-23, 1978
PubMed
22) Yamamoto F, Manning AS, Braimbridge MV et al : Calcium antagonist and myocardial protection during cardioplegic arrest. in Dhalla NS, Hearse DJ eds : Myocardial Protection in Cardiac Surgery, Plenum Press, New York, 1985, pp545-562
 
23) Guyton RA, Dorsey LM, Colgan TK et al : Calcium-channel blockade as an adjunct to heterogenous delivery of cardioplegia. Ann Thorac Surg 35 : 626-631, 1983
PubMed
24) Chiavarelli M, Chiavarelli R, Macchiarelli A et al : Calcium entry blockers and cardioplegia : Interaction between nifedipine, potassium, and hypothermia. Ann Thorac Surg 41 : 535-541, 1986
PubMed
25) Rosenkranz ER, Buckberg GD, Mulder DG et al : Warm induction of cardioplegia with glutamate enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intra-aortic balloon support : Initial experience and operative strategy. J Thorac Cardiovasc Surg 86 : 507-518, 1983
 
26) Pisarenko OI, Portnoy VF, Studneva IM et al : Glutamate-blood cardioplegia improves ATP preservation in human myocardium. Bimed Biochim Acta 46 : 499-504, 1987
 
27) Shlafer M, Kane PF, Kirsh MM et al : Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic reperfused heart. J Thorac Cardiovasc Surg 83 : 830-839, 1982
 
28) Chambers DJ, Braimbridge MV, Hearse DJ : Freeradicals and cardioplegia : Free radical scavengers improve post ischemic function of rat myocardium. Eur J Cardiothorac Surg 1 : 37-45, 1987
 
29) Adachi H, Motomatsu K, Yara I : Effect of allopurinol (zyloric) on patients undergoing open heart surgery. Jpn Circ J 43 : 395-401, 1979
PubMed
30) Tabayashi K, Suzuki Y, Nagamine S et al : A clinical trial of allopurinol (zyloric) for myocardial protection. J Thorac Cardiovasc Surg 101 : 713-718, 1991
PubMed
31) Eddy LJ, Stewart JR, Jones HP et al : Free radical-producing enzyme, xanthine oxidase is undetectable in human hearts. Am J Physiol 253 : H709-H711, 1987
PubMed
32) Follette DM, Mulder DG, Maloney JV Jr et al : Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. J Thorac Cardiovasc Surg 76 : 604-619, 1978
PubMed
33) Buckberg GD : A proposed "solution" to the cardioplegic controversy. J Thorac Cardiovasc Surg 77 : 803-815, 1979
 
34) Guru V, Omura J, Alghamdi AA et al : Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 114 (Suppl I) : 331-338, 2006
 
35) Lolley DM, Hewitt RL, Drapanas T : Retroperfusion of the heart with glucose insulin and potassium during anoxic arrest. J Thorac Cardiovasc Surg 67 : 364-374, 1974
PubMed
36) Ishizaka M : Myocardial protection by retrograde cardiac perfusion with cold modified Krebs solution through coronary sinus during complete ischemic arrest for 120 min. Nihon Kyobu Geka Gakkai Zasshi 25 : 1592-1601, 1977
 
37) Pratt FH : The nutrition of the heart through the vessels of the Thebesius and coronary veins. Am J Physiol 1 : 86, 1898
 
38) Partington MT, Acar C, Buckberg GD et al : Studies of retrograde cardioplegia. I. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg 97 : 605-612, 1989
PubMed
39) Partington MT, Acar C, Buckberg GD et al : Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg 97 : 613-622, 1989
PubMed
40) Drinkwater DC, Laks H, Buckberg GD et al : A new simplified method of optimizing cardioplegic delivery without right heart isolation. J Thorac Cardiovasc Surg 100 : 56-64, 1990
PubMed
41) Lichtenstein SV, El Dalati H, Panos A et al : Long cross-clamp times with warm heart surgery (Letter). Lancet 24 : 1443, 1989
 
42) Lichtenstein SV, Ashe KA, El Delati H et al : Warm heart surgery. J Thorac Cardiovasc Surg 101 : 269-274, 1991
 
43) Salerno TA, Houck JP, Barrozo CAM et al : Retrograde continuous warm blood cardioplegia : A new concept in myocardial protection. Ann Thorac Surg 51 : 245-247, 1991
 
44) Mezzetti A, Calafiore AM, Salerno TA et al : Intermittent antegrade warm cardioplegia. Reduces oxidative stress and improves metabolism of the ischemic-reperfused human myocardium. J Thorac Cardiovasc Surg 109 : 787-795, 1995
PubMed
45) Martin TD, Craver JM, Gott JP et al : Prospective, randomized trial of retrograde warm blood cardioplegia : myocardial benefit and neurologic threat. Ann Thorac Surg 52 : 298-302, 1994
 
46) Hayashida N, Ikonomidis JS, Weisel RD et al : The optimal cardioplegic temperature. Ann Thorac Surg 58 : 961-971, 1994
PubMed
47) Rosenkranz ER, Vinten-Johansen J, Buckberg GD et al : Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts with maintenance of arrest by multidose cold blood cardioplegic infusions. J Thorac Cardiovasc Surg 84 : 667-677, 1982
PubMed
48) Follette DM, Fey K, Buckberg GD et al : Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg 82 : 221-238, 1981
PubMed
49) Teoh KH, Christakis GT, Weisel RD et al : Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 91 : 888-895, 1986
PubMed
50) Buckberg GD : Update on current techniques of myocardial protection. Ann Thorac Surg 60 : 805-814, 1995
PubMed
51) Breda MA, Drinkwater DC, Laks H et al : Prevention of reperfusion injury in the neonatal heart with leucocyte-depleted blood. J Thorac Cardiovasc Surg 97 : 654-665, 1989
 
52) Kawata H, Sawatari K, Mayer JE Jr : Evidence for the role of neutrophils in reperfusion injury after cold cardioplegia ischemia in neonatal lambs. J Thorac Cardiovasc Surg 103 : 908-908-917, 1992
PubMed
53) Sawa Y, Matsuda H, Shimasaki Y et al : Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 108 : 1125-1131, 1994
 
54) Warren O, Alexiou C, Massey R et al : The effect of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg 31 : 665-676, 2007
PubMed
55) Fallouh HB, Bardswell SC, McLatchie LM et al : Esmolol cardioplegia : the cellular mechanism of diastolic arrest. Cardiovasc Res 87 : 552-560, 2010
PubMed
56) Arlock P, Wohlfart B, Sjoberg T et al : The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J 39 : 250-254, 2005
PubMed
57) Bessho R, Chambers DJ : Myocardial protection : the efficacy of an ultra-short-acting β-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg 122 : 993-1003, 2001
 
58) Bessho R, Chambers DJ : Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia. J Thorac Cardiovasc Surg 124 : 340-351, 2002
PubMed
59) Murry CE, Jennings RB, Reimer KA et al : Preconditioning with ischemia : a delay of lethal cell injury in ischemic myocardium. Circulation 74 : 1124-1136, 1986
PubMed
60) Zhao ZQ, Corvera JS, Halkos ME et al : Inhibition of myocardial injury by ischemic postconditioning during reperfusion : comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285 : 579-588, 2003
 
61) Xi J, McIntosh R, Shen X et al : Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 47 : 684-690, 2009
 
62) Halestrap AP, Pasdois P : The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta 1787 : 1402-1415, 2009
PubMed
63) Kambe M, Bessho R, Fujii M et al : Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administrated after onset of myocardial ischemia. Interact Cardiovasc Thorac Surg 8 : 629-634, 2009
PubMed
64) SΦndergaard T, Berg E, Staffeldt I et al : Cardioplegic cardiac arrest in aortic surgery. J Cardiovasc Surg (Torino) 16 : 288-290, 1975
 

7章 現行心筋保護法

P.62 掲載の参考文献
1) Bretschneider HJ, Hubner G, Knoll D et al : Myocardial resistance and tolerance to ischemia : physiological and biochemical basis. J Cardiovasc Surg (Torino) 16 : 241-260, 1975
PubMed
2) Hearse DJ, Stewart DA, Braimbridge MV : Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg 75 : 877-885, 1978
PubMed
3) Ishiyama N, Morita S, Nishida T et al : Different responses in adult and neonatal hearts to changes in coronary perfusion pressure. Pediatr Cardiol 27 : 13-18, 2006
PubMed
4) 小林真理子, 田ノ上禎久, 江藤政尚ほか : 日本の小児心筋保護液使用状況. アンケート調査結果. 日本小児循環器学会雑誌 23 : 533-543, 2007
Medical*Online
P.71 掲載の参考文献
1) Follet DM, Mulder DG, Maloney JV et al : Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. J Thorac Cardiovasc Surg 76 : 604-619, 1978
PubMed
2) Follet DM, Steed DL, Foglia R et al : Advantages of intermittent blood cardioplegia over intermittent ischemia during prolonged hypothermic aortic clamping. Circulation 58 (Suppl I) : 200-209, 1978
 
3) Robertson JM, Vinten-Johansen J, Buckberg GD et al : Safety of prolonged aortic clamping with blood cardioplegia. I. Glutamate enrichment in normal hearts. J Thorac Cardiovasc Surg, 88 : 395-401, 1984
PubMed
4) Rosenkranz ER, Okamoto F, Buckberg GD et al : Safety of prolonged aortic clamping with blood cardioplegia. III Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg, 91 : 428-435, 1986
PubMed
5) Rosenkranz ER, Buckberg GD : Myocardial protection during surgical coronary reperfusion. J Am Coll Cardiol 1 : 1235-1246, 1983
PubMed
6) Cunningham JN, Adams PX, Knopp EA et al : Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia. J Thorac Cardiovasc Surg 78 : 708-720, 1979
PubMed
7) Takamoto S, Levine FH, Laraia PJ et al : Comparison of single-dose and multi-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion. J Thorac Cardiovasc Surg 79 : 19-28, 1980
 
8) Robinson LA, Schwarz GD, Goddard DB et al : Myocardial protection for acquired heart disease surgery : results of a national survey. Ann Thorac Surg 59 : 361-372, 1995
PubMed
9) Kotani Y, Tweddell J, Gruber P et al : Current cardioplegia practice in pediatric cardiac surgery. A north American multiinstitutional survey. Ann Thorac Surg 96 : 923-929, 2013
PubMed
10) Follette DM, Steed DL, Foglia RP et al : Reducing postischemic myocardial damage by maintaining arrest during initial reperfusion. Surg Forum 28 : 281-283, 1977
 
11) Cunningham J, Rosenkranz ER, Okamoto F et al : Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts with maintenance of arrest by multidose cold blood cardioplegia. J Thorac Cardiovasc Surg 84 : 676-683, 1982
 
12) Beyersdorf F, Kirsh MM, Buckberg GD et al : Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death. J Thorac Cardiovasc Surg 104 : 1141-1147, 1992
 
13) Imura H, Lin H, Griffiths EJ et al : Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading. J Thorac Cardiovasc Surg 141 : 1529-1537, 2011
PubMed
14) Teoh KH, Christakis GT, Weisel RD et al : Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 91 : 888-895, 1986
PubMed
15) Hayashi Y, Sawa Y, Fukuyama N et al : Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardial derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J Thorac Cardiovasc Surg 126 : 1813-1821, 2003
PubMed
16) Toyoda Y, Yamaguchi M, Yoshimura N et al : Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg 125 : 1242-1251, 2003
PubMed
17) Modi P, Suleiman MS, Reeves B et al : Myocardial metabolic changes during pediatric cardiac surgery : a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 128 : 67-75, 2004
PubMed
18) Beyersdorf F, Buckberg GD : Myocardial protection during surgical intervention for acute myocardial infarction. Tex Heart Inst J 19 : 26-40, 1992
 
19) Rosenkranz ER, Buckberg GD, Mulder DG et al : Warm induction of cardioplegia with glutamate-enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intraaortic balloon support : Initial experience and operative strategy. J Thorac Cardiovasc Surg 86 : 507-518, 1983
 
20) O'Brien JD, Howlett SE, Burton HJ et al : Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg 87 : 1517-1524, 2009
PubMed
21) Govindapillai A, Hua R, Rose R et al : Protecting the aged heart during cardiac surgery. Use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg 146 : 940-948, 2013
 
22) MatteGS, del Nido PJ : History and Use of del Nido Cardioplegia Solution at Boston Children's Hospital. J Extra Corpor Technol 44 : 98-103, 2012
PubMed
23) Charette K, Gerrah R, Quaegebeur J et al : Single dose myocardial protection utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion 27 : 98-103, 2012
PubMed
24) Mick SL, Robich MP, Houghtaling PL et al : Del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg 149 : 626-636, 2015
 
25) Yerebakan H, Sorabella RA, Najjar M et al : Del Nido cardioplegia can be safely administered in highrisk coronary artery bypass grafting surgery after acute myocardial infarction : a propensity matched comparison. J Cardiothorac Surg 9 : 141, 2014
 
P.77 掲載の参考文献
1) Gundry SR, Kirsh MM : A comparison of retrograde cardioplegia versus antegrade cardioplegia in the presence of coronary artery obstruction. Ann Thorac Surg 38 : 124-127, 1984
PubMed
2) Menasche P, Subayi J-B, Veyssie L et al : Efficacy of coronary sinus cardioplegia in patients with complete coronary artery occlusions. Ann Thorac Surg 51 : 418-423, 1991
PubMed
3) Solorzano J, Taitelbaum G, Chiu RC : Retrograde coronary sinus perfusion for myocardial protection during cardiopulmonary bypass. Ann Thorac Surg 25 : 201-208, 1978
PubMed
4) Ardehali A, Laks H, Drinkwater DC Jr et al : Ventricular effluent of retrograde cardioplegia in human hearts has traversed capillary beds. Ann Thorac Surg 60 : 78-82, 1995
PubMed
5) Ikonomidis JS, Yau TM, Weisel RD et al : Optimal flow rates for retrograde warm cardioplegia. J Thorac Cardiovasc Surg 107 : 510-519, 1994
PubMed
6) Stirling MC, McClanahan TB, Schott RJ et al : Distribution of cardioplegic solution infused antegradely and retrogradely in normal canine hearts. J Thorac Cardiovasc Surg 98 : 1066-1076, 1989
PubMed
7) Aronson A, Lee BK, Liddicoat JR et al : Assessment of retrograde cardioplegia distribution using contrast echocardiography. Ann Thorac Surg 52 : 810-814, 1991
 
8) Menasche P, Kucharski K, Mundler O et al : Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study. Circulation 80 : III19-III24, 1989
PubMed
9) Menasche P, Fleury J-P, Droc L et al : Metabolic and functional evidence that retrograde warm blood cardioplegia does not injury the right ventricle in human beings. Circulation 90 : II310-II315, 1994
PubMed
10) Rao V, Cohen G, Weisel RD et al : Optimal flow rates for integrated cardioplegia. JTVS 115 : 226-235, 1998
 
11) 樋上哲哉, 橘一俊, 長谷川武生 : 逆行性持続性冠灌流法. CIRCULATION Up-to-Date 5 : 586-592, 2010
 
P.84 掲載の参考文献
1) Buckberg GD, Beyersdorf F, Allen BS : Integrated myocardial management in valvular heart disease. J Heart Valve Dis 4 (suppl. II) : S198-S213, 1995
 
2) Follette DM, Steed DL, Foglia RP et al : Reducing postischemic myocardial damage by maintaining arrest during initial reperfusion. Surg Forum 28 : 281-283, 1977
 
3) Buckberg GD : Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution : operative techniques and objectives. J Card Surg 4 : 216-238, 1989
PubMed
4) Buckberg GD, Drinkwater DC, Laks H : A new technique for delivering antegrade/retrograde blood cardioplegia without right heart isolation. Eur J Cardiothorac Surg 4 : 163-168, 1990
PubMed
5) Cunningham J, Rosenkranz ER, Okamoto F et al : Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts with maintenance of arrest by multidose cold blood cardioplegia. J Thorac Cardiovasc Surg 84 : 676-683, 1982
 
6) Beyersdorf F, Kirsh MM, Buckberg GD et al : Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death. J Thorac Cardiovasc Surg 104 : 1141-1147, 1992
 
7) Okamoto H, Tamenishi A, Nishi T et al : Analysis of myocardial temperature changes in convention isolated coronary artery bypass grafting. Gen Thorac Cardiovasc Surg 61 : 706-712, 2014
 
8) Caputo M, Dihmis WC, Bryan AJ et al : Warm blood hyperkalaemiac reperfusion ('hot shot') prevents myocardial substrate derangement in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 13 : 559-564, 1998
PubMed
9) Rergkliang C, Chetpaophan A, Chittithavorn V et al : Terminal warm blood cardioplegia in mitral valve replacement. Prospective study. Asian Cardiovasc Thorac Ann 14 : 134-138, 2006
PubMed
10) Hayashi Y, Sawa Y, Fukuyama N et al : Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardial derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J Thorac Cardiovasc Surg 126 : 1813-1821, 2003
PubMed
P.88 掲載の参考文献
1) Lichtenstein SV, el Dalati H, Panos A et al : Long cross-clamp times with warm heart surgery. Lancet 1 : 1443, 1989
PubMed
2) Lichtenstein SV, Ashe KA, el Dalati H et al : Warm heart surgery. J Thorac Cardiovasc Surg 101 : 269-274, 1991
PubMed
3) Mauney MC, Kron IL : The physiologic basis of warm blood cardioplegia. Ann Thorac Surg 60 : 819-823, 1995
PubMed
4) Randomised trial of normothermic versus hypothermic coronary bypass surgery. The Warm Heart Investigators. Lancet 343 : 559-563, 1994
PubMed
5) 阿部稔雄 : 心筋保護法の問題点とその対策. 総合臨床 43 : 2717, 1991
 
6) Follete DM, Fey K, Buckberg GD et al : Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity. J Thorac Cardiovasc Surg 82 : 221-238, 1981
 
7) Teoh KH, Christakis GT, Weisel RD et al : Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 91 : 888-895, 1986
PubMed
8) Kirklin JK, Neves J, Naftel DC et al : Controlled initial hyperkalemic reperfusion after cardiac transplantation : coronary vascular resistance and blood flow. Ann Thorac Surg 49 : 625-631, 1990
PubMed
9) 前原正明, 小柳博靖, 竹内成之ほか : 優れた心筋保護法と考えられるControlled aortic root reperfusion methodを用いた重症僧帽弁狭窄症の1手術経験. 日胸外会誌 39 : 80-84, 1991
 
10) Hayashida N, Ikonomidis JS, Weisel RD et al : The optimal cardioplegic temperature. Ann Thorac Surg 58 : 961-971, 1994
PubMed
11) Hayashida N, Weisel RD, Shirai T et al : Tepid antegrade and retrograde cardioplegia. Ann Thorac Surg 59 : 723-729, 1995
PubMed
12) Martin TD, Craver JM, Gott JP et al : Prospective randomized trial of retrograde warm blood cardioplegia : myocardial benefit and neurologic threat. Ann Thorac Surg 57 : 298-304, 1994
PubMed
P.90 掲載の参考文献
1) Buckberg GD : Update on current techniques of myocardial protection Ann Thorac Surg 60 : 805-814, 1995
PubMed

8章 現行心保存法

P.97 掲載の参考文献
1) Belzer FO, Southard JH : Principles of solid-organ preservation by cold storage. Transplantation 45 : 673-676, 1988
PubMed
2) Demmy TL, Biddle JS, Bennett LE et al : Organ preservation solutions in heart transplantation patterns of usage and related survival. Transplantation 63 : 262-269, 1997
PubMed
3) Lower RR, Stofer RC, Hurley EJ et al : Successful homotransplantations of the canine heart after anoxic preservation for seven hours. Am J Surg 104 : 302-306, 1962
PubMed
4) Bretschneider HJ, Huebner G, Knoll D et al : Myocardial resistance and tolerance to ischemia. Physiological and biological basis. J Cardiovasc Surg 16 : 241-260, 1975
 
5) Kirsch U, Rodewald G, Kalmar P : Induced ischemic arrest. Clinical arrest with cardioplegia in open heart surgery. J Thorac Cardiovasc Surg 63 : 121-130, 1972
PubMed
6) Hearse DJ, O'Brien K, Braimbridge MV : Protection of the myocardium during ischemic arrest. J Thorac Cardiovasc Surg 81 : 873-879, 1981
PubMed
7) Buckberg GD : A proposed "solution" to the cardioplegic controversy. J Thorac Cardiovasc Surg 77 : 803-815, 1979
 
8) Jennings RB, Sommers H, Smyth G et al : Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Path 70 : 68-78, 1960
PubMed
9) Proctor E, Parker R : Preservation of the isolated heart for 72 hours. Br Med J 4 : 296-298, 1968
PubMed
10) Wagner FM : Donor heart preservation and perfusion. App Cardiopulm Pathophysiol 15 : 198-206, 2011
 
11) Muhlbacher F, Langer F, Mittermayer C : Preservation solutions for transplantation. Transplant Proc 31 : 2069-2070, 1999
PubMed
12) Feng XN, Xu X, Zheng SS : Current status and perspective of liver preservation solutions. Hepatobiliary Pancreat Dis Int 5 : 490-494, 2006
 
13) Latchana N, Peck JR, Whitson B et al : Preservation solutions for cardiac and pulmonary donor grafts : a review of the current literature. J Thorac Dis 6 : 1143-1149, 2014
PubMed
14) 't Hart NA, Leuvenink HGD, Ploeg RJ : New solutions in organ preservation. Transplant Rev 16 : 131-141, 2002
 
15) Tierney A, Foster R, Ogella D : A perfusionist's role in lung transplant preservation. Perfusion 19 : 351-357, 2004
 
16) Roskott AM, Nieuwenhuijs VB, Dijkstra G et al : Small bowel preservation for intestinal transplantation : a review. Transpl Int 24 : 107-131, 2011
PubMed
17) Remadi JP, Baron O, Roussel JC et al : Myocardial preservation using Celsior solution in cardiac transplantation : early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantation. Ann Thorac Surg 73 : 1495-1499, 2002
PubMed
18) Wieselthaler GM, Chevtchik O, Konetschny R et al : Improved graft function using a new myocardial preservation solution : Celsior. Preliminary data from a randomized prospective study. Transplant Proc 31 : 207-208, 1999
 
19) Vega JD, Ochsner JL, Jeevanandam V et al : A multicenter, randomized controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg 71 : 1442-1447, 2001
PubMed
20) Cannata A, Botta L, Colombo T et al : Does the cardioplegic solution have an effect on early outcomes following heart transplantation? Eur J Cardiothorac Surg 41 : e48-e52, discussion e52-e53, 2012
 
21) Kofler S, Bigdeli AK, Kaczmared I et al : Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center. Tranpl Int 22 : 1140-1150, 2009
 
22) George TJ, Arnaoutakis GJ, Beaty CA et al : A novel method of measuring cardiac preservation injury demonstrates University of Wisconsin solution is associated with less ischemic necrosis than Celsior in early cardiac allografts biopsy specimens. J Heart Lung Transplant 31 : 410-418, 2012
PubMed
23) Garlicki M, Koltcz, J, Rudzinski P et al : Myocardial protection for transplantation. Transplant Proc 31 : 2079-2083, 1999
 
24) George TJ, Arnaoutakis GJ, Baumgartner WA et al : Organ storage with University of Wisconsin solution is associated with improved outcomes after orthotopic heart transplantation. J Heart Lung Transplant 30 : 1033-1043, 2011
PubMed
25) Tenderich G, Tsui S, El-Banayosy A et al : The one-year follow up of the "Protect" patient population using the organ care system. J Heart Lung Transplant 27 : 166, 2008
 
26) McCurry K, Jeevanandam V, Mihalijevic T et al : Prospective multicenter safety and effectiveness evaluation of the organ care system device for cardiac use (PROCEED). J Heart Lung Transplant 27 : S166, 2008
 
27) Ardehali A, Esmailian F, Deng M et al : Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II) : a prospective, open-label, multicenter, randomized non-inferiority trial. Lancet 385 : 2577-2584, 2015
 

9章 心保存の手技

P.105 掲載の参考文献
1) Fukushima N, Ono M, Nakatani T et al : Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplant Proc 41 : 273-276, 2009
PubMed
2) Sawa Y, Taniguchi K, Kadoba K et al : Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation 93 : 1640-1646, 1996
PubMed
3) Fukushima N, Shirakura R, Nakata S et al : Effects of terminal cardioplegia with leukocyte depleted blood on heart grafts preserved for 24 hours. J Heart Lung Transplant 11 : 676-682, 1992
 
4) Matsuda H, Fukushima N, Sawa Y et al : First brain dead donor heart transplantation under new legislation in Japan. Jpn J Thorac Cardiovasc Surg 47 : 499-505, 1999
PubMed

10章 新しい心筋保護・心保存の未来像 - 心筋再生効果を有する薬剤を用いた新しい心筋虚血再灌流傷害治療法 -

P.109 掲載の参考文献
1) Turer AT, Hill JA : Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol 106 : 360-368, 2010
PubMed
2) Shirasaka T, Miyagawa S, Fukushima S et al : A slow-releasing form of prostacyclin agonisf (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure. J Thorac Cardiovasc Surg 146 : 413-421, 2013
 
3) Ishimaru K, Miyagawa S, Fukushima S et al : Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy : a promising regenerative therapy for the failing heart. J Thorac Cardiovasc Surg 146 : 1516-1525, 2013
 
4) Imanishi Y, Miyagawa S, Fukushima S et al : Sustained-release delivery of prostacyclin analogue enhances bone marrow-cell recruitment and yields functional benefits for acute myocardial infarction in mice. PloS One 8 : e69302, 2013
PubMed
5) Hirata Y, Kurobe H, Uematsu E et al : Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model. Eur J Pharmacol 699 : 81-87, 2013
PubMed
6) Kataoka M, Nagaya N, Satoh T et al : A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med 172 : 1575-1580, 2005
 
7) Hirata Y, Shimabukuro M, Uematsu E et al : A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury. Eur J Pharmacol 674 : 352-358, 2012
PubMed

11章 術中心筋保護の手技

P.121 掲載の参考文献
1) Lillehei CW, Dewall RA, Gott VL et al : The direct vision correction of calcific aortic stenosis by means of a pump-oxygenator and retrograde coronary sinus perfusion. Dis Chest 30 : 123-132, 1956
PubMed

12章 術中心筋保護の管理

P.131 掲載の参考文献
1) Reitsma S, Slaaf DW, Vink H et al : The endothelial glycocalyx : composition, functions, and visualization. Eur J Physiol 454 : 345-359, 2007
 
2) van den Berg BM, Vink H, Spaan JA : The endothelial glycocalyx protects against myocardial edema. Circ Res 92 : 592-594, 2003
PubMed
3) Lindner JR, Ismail S, Spotnitz WD et al : Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation 98 : 2187-2194, 1998
PubMed
4) Agarwal SK, Ghosh PK, Gupta D : Cardiac surgery and cold-reactive proteins. Ann Thorac Surg 60 : 1143-1150, 1995
PubMed
5) Atkinson VP, Soeding P, Horne G et al : Cold agglutinins in cardiac surgery : management of myocardial protection and cardiopulmonary bypass. Ann Thorac Surg 85 : 310-311, 2008
PubMed
6) Foglia RP, Stead DL, Follette DM et al : Iatrogenic myocardial edema with potassium cardioplegia. J Thorac Cardiovasc Surg 78 : 217-222, 1979
 
7) Ruengsakulrach P, Buxton BF : Anatomic and hemodynamic considerations influencing the efficiency of retrograde cardioplegia. Ann Thorac Surg 71 : 1389-1395, 2001
PubMed
8) Warren O, Alexiou C, Massey R et al : The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg 31 : 665-676, 2007
PubMed

13章 手術室やICUにおける心筋保護効果の評価

P.139 掲載の参考文献
1) 新見能成 (監訳) : 心筋保護. in : 人工心肺 その原理と実際. メディカル・サイエンス・インターナショナル, 東京, 2010, pp170-185
 
2) Lang RM, Badano LP, Mor-Avi V et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28 : 1-39.e14, 2015
 
3) Nagueh SF, Appleton CP, Gillebert TC et al : Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22 : 107-133, 2009
PubMed
4) Casthely PA, Shah C, Mekhjian H et al : Left ventricular diastolic function after coronary artery bypass grafting : a correlative study with three different myocardial protection techniques. J Thorac Cardiovasc Surg 114 : 254-260, 1997
PubMed
5) 許俊鋭, 山本文雄, 北村惣一郎ほか : 心臓外科手術における体外循環. in : 望月正武, 堀正二編 : 心筋保護の臨床 ベッドサイドから分子メカニズムまで. 南江堂, 東京, 1999, pp135-150
 
6) Petzold T, Feindt P, Sunderdiek U et al : Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 19 : 859-864, 2001
 
7) Guru V, Omura J, Alghamdi AA et al : Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 114 : I331-I338, 2006
PubMed
8) Nesher N, Alghamdi AA, Singh SK et al : Troponin after cardiac surgery : a predictor or a phenomenon? Ann Thorac Surg 85 : 1348-1354, 2008
PubMed
9) Svedjeholm R, Dahlin LG, Lundberg C et al : Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery? Eur J Cardiothorac Surg 13 : 655-661, 1998
PubMed
10) Muehlschlegel JD, Perry TE, Liu K-Y et al : Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J 30 : 1574-1583, 2009
PubMed
11) 清野精彦 : 虚血心の心機能評価 : 血液生化学バイオマーカー. 冠疾患誌 13 : 115-120, 2007
 
12) 小林宣明, 清野精彦 : 急性冠症候群のバイオマーカー-診断から治療評価へ-. ICUとCCU 37 : 27-33, 2013
Medical*Online
13) Birdi I, Angelini GD, Bryan AJ : Biochemical markers of myocardial injury during cardiac operations. Ann Thorac Surg 63 : 879-884, 1997
PubMed
14) Januzzi JL : What is the role of biomarker measurement after cardiac surgery? Minerva Anestesiol 77 : 334-341, 2011
PubMed
15) 永井利幸 : バイオマーカー. in : 香坂俊編 : 循環器急性期診療Critical Care Cardiology. メディカル・サイエンス・インターナショナル, 東京 2015, pp295-302
 
16) Mohammed AA, Agnihotri AK, van Kimmenade RRJ et al : Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation 120 : 843-850, 2009
PubMed

14章 基礎 ( 併存 ) 疾患を有する症例の心筋保護

P.147 掲載の参考文献
1) Lindpaintner K, Ganten D : The cardiac renin-angiotensin system : an appraisal of present experimental and clinical evidence. Circ Res 68 : 905-921, 1991
PubMed
2) Komuro I, Kurabayashi M, Takaku F et al : Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overload hypertrophy of the rat heart. Circ Res 62 : 1075-1079, 1988
PubMed
3) Komuro I, Kurabayashi M, Shibazaki Y et al : Molecular cloning and characterization of a Ca2+ + Mg2+ -dependent adenosine triphosphate from rat cardiac sarcoplasmic reticulum. J Clin Invest 83 : 1102-1108, 1989
 
4) Minakawa M, Takeuchi K, Ito K et al : Restoration of sarcoplasmic reticulum protein level by thyroid hormone contributes to partial improvement of myocardial function but not to glucose metabolism in an early failing heart. Eur J Cardiothorac Surg 24 : 493-501, 2003
PubMed
5) Takeuchi K, McGowan FX Jr, Glynn P et al : Glucose transporter up-regulation improves ischemic tolerance in hypertrophied failing myocardium. Circulation 98 : II234-II241, 1998
 
6) Chang KC, Figueredo VM, Schreur JHM et al : Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+ -ATPase and α-myosin heavy chain in rat hearts. J Clin Invest 100 : 1745-1749, 1997
 
7) Weinstein SP, O'Boyle E, Haber RS : Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression. Diabetes 43 : 1185-1189, 1994
PubMed
8) Weber KT, Brilla CG : Pathological hypertrophy and cardiac interstitium : fibrosis and renin-angiotensinaldosterone system. Circulation 83 : 1849-1865, 1991
 
9) Yamakado T, Nakano T : Left ventricular systolic and diastolic function in the hypertrophied ventricle. Jpn Circ J 54 : 554-562, 1990
PubMed
10) Rubler S, Dlugash J, Yuceoglu YZ et al : New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30 : 595-602, 1972
PubMed
11) Ryden L, Grant PJ, Anker SD et al : ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD : The Task Force on diabetes, pre-diabetes, and cardio vascular diseases of European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34 : 3035-3087, 2013
 
12) Poornima IG, Parikh P, Shannon RP : Diabetic cardiomyopathy. The search for a unifying hypothesis. Circ Res 98 : 596-605, 2006
PubMed
13) Zhang X, Chen C : A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy. Endocrine 41 : 398-409, 2012
 
14) McCullough PA, Kellum JA, Haase M et al : Pathophysiology of the cardiorenal syndromes : executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182 : 82-98, 2013
PubMed
15) Hundae A, McCullough PA : Cardiac and renal fibrosis in chronic cardiorenal syndromes. Nephron Clin Pract 127 : 106-112, 2014
PubMed
16) Taylor D, Bhandari S, Seymour AM : Mitochondrial dysfunction in uremic cardiomyopathy. Am J Physiol Renal Physiol 308 : F579-F587, 2015
PubMed
17) Richardson P, McKenna W, Bristow M et al : Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 : 841-842, 1996
PubMed
18) 循環器病の診断と治療に関するガイドライン (2009-2010年度合同研究班報告). 拡張型心筋症ならびに関連する二次性心筋症の診療に関するガイドライン http://www.j-circ.or.jp/guideline/pdf/JCS2011_tomoike_h.pdf
 
19) Takeuchi K, Minakawa M, Otani M et al : Hyperthyroidism causes mechanical insufficiency of myocardium with possibly increased SR Ca2+-ATPase activity. Jpn J Physio 53 : 411-416, 2003
 
20) Ohga Y, Sakata S, Takenaka C et al : Cardiac dysfunction in terms of left ventricular mechanical work and energetics in hypothyroid rats. Am J Physiol Heart Circ Physiol 283 : H631-H641, 2002.
PubMed
21) 佐藤洋 : カテコールアミンと心筋障害. in 堀正二編 : 心筋障害と心筋保護. 医学書院, 東京, 1997, pp40-45
 

15章 各疾患における開心術中心筋保護

P.151 掲載の参考文献
1) Robinson LA, Schwarz GD, Goddard DB et al : Myocardial Protection for Acquired Heart Disease Surgery : Results of a National Survey. Ann Thorac Surg 59 : 361-372, 1995
PubMed
2) Rosenkranz ER, Okamoto F, Buckberg GD et al : Safety of prolonged aortic clamping with blood cardioplegia. III Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury. J Thorac Cardiovasc Surg 91 : 428-435, 1986
PubMed
3) Kotani Y, Tweddell J, Gruber P et al : Current cardioplegia practice in pediatric cardiac surgery. A north American multiinstitutional survey. Ann Thorac Surg 96 : 923-929, 2013
PubMed
4) Govindapillai A, Hua R, Rose R et al : Protecting the aged heart during cardiac surgery. Use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg 146 : 940-948, 2013
 
5) Matte GS, del Nido PJ : History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 44 : 98-103, 2012
PubMed
6) Charette K, Gerrah R, Quaegebeur J et al : Single dose myocardial protection utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion 27 : 98-103, 2012
PubMed
7) Mick SL, Robich MP, Houghtaling PL et al : Del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg 149 : 626-636, 2015
 
8) Yerebakan H, Sorabella RA, Najjar M et al : Del Nido cardioplegia can be safely administered in highrisk coronary artery bypass grafting surgery after acute myocardial infarction : a propensity matched comparison. J Cardiothorac Surg 9 : 141, 2014
 
9) Loop FD, Higgins TL, Panda R et al : Myocardial protection during cardiac operations : decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 104 : 608-618, 1992
PubMed
10) Takamoto S, Levine FH, LaRaia PJ et al : Comparison of single-dose and multi-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion. J Thorac Cardiovasc Surg 79 : 19-28, 1980
 
11) Fremes SF, Christakis GT, Weisel RD et al : A clinical trial of blood and crystalloid cardioplegia. J Thorac Cardiovasc Surg 88 : 726-741, 1984
 
12) Braathen B, Tonnessen T : Cold blood cardioplegia reduces the increases in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. J Thorac Cardiovasc Surg 139 : 874-880, 2010
PubMed
13) Ovrum E, Tangen G, Tollofsrud S et al : Cold blood cardioplegia versus cold crystalloid cardioplegia : a prospective randomized study of 1440 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 : 860-865, 2004
PubMed
14) Guru V, Omura J, Alghamdi AA et al : Is Blood Superior to Crystalloid Cardioplegia? A Meta-Analysis of Randomized Clinical Trials. Circulation 114 : I331-I338, 2006
PubMed
15) Young JN, Choy IO, Silva NK et al : Antegrade cold blood cardioplegia is not demonstrably advantageous over cold crystalloid cardioplegia in surgery for congenital heart disease. J Thorac Cardiovasc Surg 114 : 1102-1109, 1997
PubMed
16) Chaturvedi R, Lincoln C, Gothard J et al : Left ventricular dysfunction after open repair of simple congenital heart defects in infants and children : quantitation with the use of a conductance catheter immediately after bypass. J Thorac Cardiovasc Surg 115 : 77-83, 1998
PubMed
17) Amark K, Berggren H, Bjork K et al : Blood cardioplegia provides superior protection in infant cardiac surgery. Ann Thorac Surg 80 : 989-994, 2005
PubMed
18) Caputo M, Modi P, Imura H et al : Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric heart surgery : a randomized controlled trial. Ann Thorac Surg 74 : 530-534, 2002
PubMed
19) Modi P, Suleiman MS, Reeves B et al : Myocardial metabolic changes during pediatric cardiac surgery : a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 128 : 67-75, 2004
PubMed
P.158 掲載の参考文献
1) Lattouf OM, Thourani VH, Kilgo PD et al : Influence of on-pump versus off-pump techniques and completeness of revascularization on long-term survival after coronary artery bypass. Ann Thorac Surg 86 : 797-805, 2008
 
2) Puskas JD, Kilgo PD, Lattouf OM et al : Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann Thorac Surg 86 : 1139-1146, 2008
PubMed
3) Raja SG : Pump or no pump for coronary artery bypass : current best available evidence. Tex Heart Inst J 32 : 489-501, 2005
 
4) Al-Ruzzeh S, George S, Bustami M et al : Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive, and quality of life outcomes : randomised controlled trial. BMJ 332 : 1365, 2006
PubMed
5) Puehler T, Haneya A, Philipp A et al : Minimal extracorporeal circulation : an alternative for on-pump and off-pump coronary revascularization. Ann Thorac Surg 87 : 766-772, 2009
PubMed
6) Benedetto U, Ng C, Frati G et al : Miniaturized extracorporeal circulation versus off-pump coronary artery bypass grafting : a meta-analysis of randomized controlled trials. Int J Surg 14 : 96-104, 2015
PubMed
7) Remadi JP, Rakotoarivelo Z, Marticho P et al : Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation Jostra System or with a standard cardiopulmonary bypass. Am Heart J 151 : 198, 2006
PubMed
8) Wiesenack C, Liebold A, Philipp A et al : Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 28 : 1082-1088, 2004
PubMed
9) Immer FF, Pirovino C, Gygax E et al : Minimal versus conventional cardiopulmonary bypass : assessment of intraoperative myocardial damage in coronary bypass surgery. Eur J Cardiothorac Surg 28 : 701-704, 2005
PubMed
10) Ohata T, Mitsuno M, Yamamura M et al : Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting. J Artif Organs 10 : 92-95, 2007
PubMed
11) Fromes Y, Gaillard D, Ponzio O et al : Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22 : 527-533, 2002
PubMed
12) Wippermann J, Albes JM, Hartrumpf M et al : Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients : selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg 28 : 127-132, 2005
PubMed
13) Mazzei V, Nasso G, Salamone G et al : Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation 116 : 1761-1767, 2007
PubMed
14) Murry CE, Jennings RB, Reimer KA : Preconditioning with ischemia : A delay of lethal cell injury in ischemic myocardium. Circulation 74 : 1124-1136, 1986
PubMed
15) Yellon DM, Downey JM : Preconditioning the myocardium : From cellular physiology to clinical cardiology. Physiol Rev 83 : 1113-1151, 2003
PubMed
16) Yellon DM, Alkhulaifi AM, Pugsley WB : Preconditioning the human myocardium. Lancet 342 : 276-277, 1993
PubMed
17) Jenkins DP, Pugsley WB, Alkhulaifi AM et al : Ischaemiac preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77 : 314-318, 1997
PubMed
18) Walsh SR, Tang TY, Kullar P et al : Ischaemiac preconditioning during cardiac surgery : Systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardio-thorac Surg 34 : 985-994, 2008
 
19) Przylenk K, Bauer B, Ovize M et al : Regional ischemic 'Preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87 : 893-899, 1993
 
20) Birnbaum Y, Hale SL, Kloner RA : Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96 : 1641-1646, 1997
 
21) Gunaydin B, Cakici I, Soncul H et al : Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 41 : 493-496, 2000
PubMed
22) Kharbanda RK, Mortensen UM, White PA et al : Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106 : 2881-2883, 2002
PubMed
23) Venugopal V, Hausenloy DJ, Ludman A et al : Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia : a randomized controlled trial. Heart 95 : 1567-1571, 2009
PubMed
24) Hong DM, Jeon Y, Lee CS et al : Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery. Randomized controlled trial. Circ J 76 : 884-890, 2012
PubMed
25) Marczak J, Nowicki R, Kulbacka J et al : Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg 14 : 634-639, 2012
PubMed
P.164 掲載の参考文献
1) Menasche P : Blood cardioplegia : do we still need to dilute? Ann Thorac Surg 62 : 957-960, 1996
PubMed
2) McCann UG, Lutz CJ, Picone AL et al : Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass. J Extra Corpor Technol 38 : 14-21, 2006
PubMed
3) Velez DA, Morris CD, Budde JM et al : All-blood (miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction. Circulation 104 (Suppl 1) : I296-I302, 2001
 
4) el-Hamamsy I, Stevens LM, Pellerin M et al : A prospective randomized study of diluted versus non-diluted cardioplegia (minicardioplegia) in primary coronary artery bypass surgery. J Cardiovasc Surg (Torino) 45 : 101-106, 2004
 
5) Albacker TB, Chaturvedi R, Al Kindi AH et al : The effect of microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg 9 : 56-60, 2009
PubMed
6) Gong B, Ji B, Sun Y et al : Is microplegia really superior to standard blood cardioplegia? The results from a meta-analysis. Perfusion 30 : 375-382, 2015
PubMed
P.168 掲載の参考文献
1) Athanasuleas C, Siler W, Buckberg G : Myocardial protection during surgical ventricular restoration. Eur J Cardiothorac Surg 29 (Suppl 1) : S231-S237, 2006
 
2) Athanasuleas CL, Buckberg GD, Stanley AW et al : Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol 44 : 1439-1445, 2004
PubMed
3) Mickleborough LL, Merchant N, Ivanov J et al : Left ventricular reconstruction : early and late results. J Thorac Cardiovasc Surg 128 : 27-37, 2004
PubMed
4) Athanasuleas CL, Stanley AWH Jr, Buckberg GD et al : Restoration of contractile function in the enlarged left ventricle by exclusion of remodeled akinetic anterior segment : surgical strategy, myocardial protection, and angiographic results. J Card Surg 13 : 418-428, 1998
 
5) Ravichandran PS, Alsoufi B, Buckberg GD et al : Surgical anterior ventricular restoration in patients with aortic regurgitation. Ann Thorac Surg 78 : 1100-1102, 2004
PubMed
6) D'Onofrio A, Cugola D, Di Donato M et al : Surgical ventricular reconstruction with different myocardial protection strategies. A propensity matched analysis. Interact Cardiovasc Thorac Surg 10 : 530-534, 2010
PubMed
P.173 掲載の参考文献
1) Kunihara T, Grun T, Aicher D et al : Hypothermic circulatory arrest is not a risk factor for neurologic morbidity in aortic surgery : a propensity score analysis. J Thorac Cardiovasc Surg 130 : 712-718, 2005
 
2) Kazui T, Washiyama N, Muhammad BA et al : Total arch replacement using aortic arch branched grafts with the aid of antegrade selective cerebral perfusion. Ann Thorac Surg 70 : 3-8, 2000
PubMed
P.183 掲載の参考文献
1) 新見能成 (監訳) : 新生児と乳児の心筋保護. in : 人工心肺 その原理と実際. メディカルサイエンスインターナショナル, 東京, 2010, pp681-690
 
2) 小林真理子, 田ノ上禎久, 江藤政尚ほか : 日本の小児心筋保護液使用状況-アンケート調査結果-. 日小児循環器会誌 23 : 533-543, 2007
Medical*Online
3) Mavroudis C, Gevitz M, Ring WS et al : The society of thoracic surgeons national congenital heart surgery database report. Ann Thorac Surg 68 : 601-624, 1999
 
4) Kotani Y, Tweddell J, Gruber P et al : Current cardioplegia practice in pediatric cardiac surgery. A north American multiinstitutional survey. Ann Thorac Surg 96 : 923-929, 2013
PubMed
5) Toyoda Y, Yamaguchi M, Yoshimura N et al : Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg 125 : 1242-1251, 2003
PubMed
6) Modi P, Suleiman MS, Reeves B et al : Myocardial metabolic changes during pediatric cardiac surgery : a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 128 : 67-75, 2004
PubMed
7) Rosenkranz ER, Buckberg GD : Myocardial protection during surgical coronary reperfusion. J Am Coll Cardiol 1 : 1235-1246, 1983
PubMed
8) Imura H, Lin H, Griffiths EJ et al : Controlled hyperkalemic reperfusion with magnesium rescues ischemic juvenile hearts by reducing calcium loading. J Thorac Cardiovasc Surg 141 : 1529-1537, 2011
PubMed
9) Lichtenstein SV, Ashe KA, Dalati H et al : Warm heart surgery. J Thorac Cardiovasc Surg 101 : 269-274, 1991
PubMed
10) Salerno TA, Houck JP, Barrozo CA et al : Retrograde continuous warm blood cardioplegia : A new concept in myocardial protection. Ann Thoracic Surg 51 : 245-247, 1991
 
11) Durandy Y, Hulin S : Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease : Clinical experience with 1400 cases. J Thorac Cardiovasc Surg 133 : 241-246, 2007
 
12) Durandy Y, Younes M, Mahut B : Pediatric warm open heart surgery and prolonged cross-clamp time. Ann Thorac Surg 86 : 1941-1947, 2008
PubMed
13) Young JN, Choy IO, Silva NK et al : Antegrade cold blood cardioplegia is not demonstrably advantageous over cold crystalloid cardioplegia in surgery for congenital heart disease. J Thorac Cardiovasc Surg 114 : 1102-1109, 1997
PubMed
14) Caputo M, Modi P, Imura H et al : Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric heart surgery : a randomized controlled trial. Ann Thorac Surg 74 : 530-534, 2002
PubMed
15) Amark K, Berggren H, Bjork K et al : Blood cardioplegia provides superior protection in infant cardiac surgery. Ann Thorac Surg 80 : 989-994, 2005
PubMed
16) Kronon MT, Allen BS, Hernan J et al : Superiority of magnesium cardioplegia in neonatal myocardial protection. Ann Thorac Surg 68 : 2285-2291, 1999
PubMed
17) Matte GS, del Nido PJ : History and use of del Nido Cardioplegia Solution at Boston Children's Hospital. J Extra Corpor Technol 44 : 98-103, 2012
PubMed
18) Charette K, Gerrah R, Quaegebeur J et al : Single dose myocardial protection utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion 27 : 98-103, 2012
PubMed
19) O'Brien JD, Howlett SE, Burton HJ et al : Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg 87 : 1517-1524, 2009
PubMed
20) Rebeyka IM, Hanan SA, Borges MR et al : Rapid cooling contracture of the myocardium. The adverse effect of prearrest cardiac hypothermia. J Thorac Cardiovasc Surg 100 : 240-249, 1990
PubMed
21) Aoki M, Nomura F, Kawata H et al : Effect of calcium and preischemic hypothermia on recovery of myocardial function after cardioplegic ischemia in neonatal lambs. J Thorac Cardiovasc Surg 105 : 207-213, 1993
PubMed
22) Sokora N, Lacis A, Kasyanov V et al : The proper delivery pressure for cardioplegic solution in neonatal cardiac surgery. An investigation of biomechanical and structural properties of neonatal and adult coronary arteries. Perfusion 28 : 357-367, 2013
 
23) Kronon M, Bolling KS, Allen BS et al : The importance of cardioplegic infusion pressure in neonatal myocardial protection. Ann Thorac Surg 66 : 1358-1364, 1998
PubMed
24) Hayashi Y, Sawa Y, Fukuyama N et al : Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardial derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes. J Thorac Cardiovasc Surg 126 : 1813-1821, 2003
PubMed
25) Fujiwara T, Kurtts T, Silver M et al : Physical and pharmacological manipulation of reperfusion condition in neonatal myocardial preservation. Circulation 78 (Suppl II) : II444, 1988
 
26) Sawatari K, Kadoba K, Bergner B et al : Influence of initial reperfusion pressure after hypothermic cardioplegic ischemia on endothelial modulation of coronary tone in neonatal lambs. J Thorac Cardiovasc Surg 101 : 777-782, 1991
 
27) Teoh KH, Mickle DA, Weisel RD et al : Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg 104 : 159-164, 1992
PubMed
28) Cavarocchi NC, England MD, Schaff HV et al : Oxygen free radical generation during cardiopulmonary bypass : correlation with complement activation. Circulation 74 : III130-III133, 1986
PubMed
29) Buckberg GD : Studies of hypoxemic/reoxygenation injury : I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc Surg 110 : 1164-1170, 1995
PubMed
30) Morita K, Ihnken K, Buckberg GD et al : Studies of hypoxemic/reoxygenation injury without aortic cross clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis. J Thorac Cardiovasc Surg 110 : 1235-1244, 1995
 
31) Morita K, Ihnken K, Buckberg GD et al : Studies of hypoxemic/reoxygenation injury with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis : a new concept of controlled cardiac reoxygenation. J Thorac Cardiovasc Surg 110 : 1265-1273, 1995
PubMed
32) Morita K, Ihnken K, Buckberg GD et al : Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest 93 : 2658-2666, 1994
PubMed
33) Bulutcu FS, Bayndir O, Polat B et al : Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children? J Cardiothorac Vasc Anesth 16 : 330-333, 2002
 
34) Modi P, Imura H, Caputo M et al : Cardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg 124 : 1035-1036, 2002
PubMed
35) Zhu ZQ, Su ZK, Zhu DM et al : The role of graded reoxygenation with cardiopulmonary bypass in prevention of reoxygenation injury and its safety. Zhonghua Yi Xue Za Zhi 85 : 614-617, 2005
PubMed
36) Caputo M, Mokhtari, A, Rogers CA et al : The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery : A randomized controlled trial. J Thorac Cardiovasc Surg 138 : 206-214, 2009
PubMed

18章 心筋保護関連材料の現状および業務施行上の安全管理

P.215 掲載の参考文献
1) 岸宗宏, 富永智, 神谷勝弘ほか : 人工心肺装置HAS型の開発における工夫-より高い機能性, 安全性を目指して-. 体外循環技術 27 : 20-23, 2000
Medical*Online
2) 日本胸部外科学会 : 人工心肺関連カニューレにおける製造中止品目一覧. 2015 http://www.jpats.org/uploads/uploads/files/150528_list_1.pdf
 
3) Kuki S, Yoshida K, Izutani H et al : Multichannel myocardial temperature probe. Ann Thorac Surg 57 : 1033-1034, 1994
PubMed
4) 日本体外循環技術医学会 : 人工心肺における安全装置設置基準の勧告. 2007 http://jasect.umin.ac.jp/safety/anzenkankoku070427.pdf
 
5) 高井浩司, 安野誠, 薗田誠ほか : 人工心肺における安全管理の現状-JaSECT アンケート2013のインシデント報告より-. 体外循環技術 42 : 381-392, 2015
Medical*Online
6) 日本臨床工学技士会 : 生命維持管理装置領域における医薬品等の調製業務の安全対策指針. 2000 http://www.ja-ces.or.jp/03publish/pdf/safety_v100_.pdf
 
7) 日本体外循環技術医学会 : 医療機器安全性情報「心筋保護液回路からの空気誤送について」. 2007 http://jasect.umin.ac.jp/safety/Safty%202012.02.14%20CP.pdf
 
8) 吉田靖, 山田憲嗣 : 人工心肺事故の現状と安全対策, 環境整備. 人工臓器 42 : 228-231, 2013
 

19章 さらに勉強したい人のための参考図書および参考文献集

P.216 掲載の参考文献
Bers DM : Cardiac excitation-contraction coupling. Nature 415 : 198-205, 2002 (4章)
 
Bolli R, Marban E : Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79 : 609-634, 1999 (5章)
 
Geers C, Gros G : Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 80 : 681-715, 2000 (5章)
 
Hausenloy DJ, Yellon DM : Myocardial ischemia-reperfusion injury : a neglected therapeutic target. J Clin Invest 123 : 92-100, 2013 (4章)
 
Hearse DJ, Braimbrige MV, Jynge P : Protection of Ischemic Myocardium : Cardioplegia. Raven Press, 1981 (1・6・12章)
 
Katz AM : Physiology of the Heart, 5th ed. Lippincott Williams & Wilkins, 2010 (1章)
 
Khonsari S, Sintek CF : Cardiac Surgery : Safeguards and Pitfalls in Operative Technique, 4th ed. Lippincott Williams & Wilkins, 2007 (11章)
 
Lakatta EG : Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73 : 413-467, 1993 (2・3章)
 
Opie LH : The Heart. Physiology, from Cell to Circulation, 3 rd ed. Lippincott-Raven Publishers, 1998 (1章)
 
Salerno TA : Warm Heart Surgery. Arnold, 1995 (1章)
 
Yellon DM, Hausenloy DJ : Myocardial reperfusion injury. N Engl J Med 357 : 1121-1135, 2007 (4章)
 
P.217 掲載の参考文献
安達秀雄, 百瀬直樹 : 人工心肺トラブルシューティング, 改訂2版. 中外医学社, 2014 (18章)
 
阿部稔雄 (監訳) : 心筋保護法 基礎と臨床. 名古屋大学出版会, 1988 (1・5・6・12章)
 
天野篤 (監訳) : 心臓手術の周術期管理. メディカル・サイエンス・インターナショナル, 2008 (18章)
 
石川統, 山岸明彦, 河野重行 ほか : シリーズ進化学 化学進化・細胞進化. 岩波書店, 2004 (1章)
 
後藤昌義 : 心臓の生理. 南江堂, 1984 (1章)
 
中村運 : 新・細胞の起源と進化 生命のしくみを探る. 培風館, 2006 (1章)
 
新見能成 (監訳) : 人工心肺 その原理と実際. メディカル・サイエンス・インターナショナル, 2010 (13・18章)
 
新見能成 (監訳) : 心臓手術の麻酔, 第4版. メディカル・サイエンス・インターナショナル, 2014 (18章)
 
日本心臓財団「心臓」編集委員会 (編) : 心血管系の発生・老化と心疾患. 月刊心臓43 : 587-619, 2011 (2・3章)
 
堀正二 (編) : 心筋障害と心筋保護. 医学書院, 1997 (14章)
 
松田暉 (監), 布田伸一, 福嶌教偉 (編) : 心臓移植. 丸善出版, 2012 (7・8・9章)
 
山下武志 : 心筋細胞の電気生理学-イオンチャネルから, 心電図, 不整脈へ-. メディカル・サイエンス・インターナショナル, 2002 (1章)
 

書評

最近チェックした商品履歴

Loading...